Barclays PLC
F:BCY2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Barclays PLC
F:BCY2
|
UK |
|
D
|
Dollarama Inc
OTC:DLMAF
|
CA |
|
Aspen Pharmacare Holdings Ltd
F:LDZA
|
ZA |
|
F
|
Factset Research Systems Inc
XMUN:FA1
|
US |
|
G
|
General Engineering PCL
SET:GEL
|
TH |
|
D
|
Diageo PLC
SWB:GUI
|
UK |
|
Saipem SpA
MIL:SPM
|
IT |
|
Royalty Pharma PLC
NASDAQ:RPRX
|
US |
|
S
|
Steel Dynamics Inc
SWB:SD5
|
US |
|
A
|
ASTI Holdings Ltd
SGX:575
|
SG |
|
WillScot Holdings Corp
F:WS11
|
US |
|
Ems Chemie Holding AG
F:EMC1
|
CH |
|
D
|
Davide Campari Milano NV
F:58H
|
IT |
|
Regeneron Pharmaceuticals Inc
LSE:0R2M
|
US |
|
B
|
Biogen Inc
XHAM:IDP
|
US |
|
Intuit Inc
NASDAQ:INTU
|
US |
|
Henkel AG & Co KGaA
F:HEN
|
DE |
|
J
|
JPMorgan Chase & Co
SWB:CMC
|
US |
|
B
|
Banco Santander Brasil SA
SWB:DBSA
|
BR |
|
T
|
Toronto-Dominion Bank
F:TDB
|
CA |
|
U
|
US Bancorp
BMV:USB
|
US |
Multiples-Based Value
The Multiples-Based Value for
Barclays PLC (BCY2) under the Base Case is hidden
EUR.
Compared with the current market price of 21.6 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.